
EUROFINS SCI.EO 0,01
Share · FR0014000MR3 · A2QJCT (XPAR)
No Price
27.10.2025 19:54
Current Prices from EUROFINS SCI.EO 0,01
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
WIENER BOERSE AG |
ESF.VI
|
EUR
|
27.10.2025 14:30
|
61,58 EUR
| -1,62 EUR
-2,56 %
|
Invested Funds
The following funds have invested in EUROFINS SCI.EO 0,01:
Fund | Vol. in million 11.570,40 | Percentage (%) 2,02 % |
Fund | Vol. in million 3.612,11 | Percentage (%) 1,65 % |
Fund | Vol. in million 506,94 | Percentage (%) 1,16 % |
Fund | Vol. in million 711,16 | Percentage (%) 0,96 % |
Fund | Vol. in million 708,20 | Percentage (%) 0,83 % |
Company Profile for EUROFINS SCI.EO 0,01 Share
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 130,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; and testing for persistent organic pollutants, dioxins and organic contaminants, pesticides, mycotoxins, allergens, and pathogens and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Company Data
Name EUROFINS SCI.EO 0,01
Company Eurofins Scientific SE
Website
https://www.eurofins.com
Primary Exchange
Paris
WKN A2QJCT
ISIN FR0014000MR3
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Gilles G. Martin
Market Capitalization 12 Mrd.
Country Luxembourg
Currency EUR
Employees 62,7 T
Address 23 Val Fleuri, 1526 Luxembourg City
IPO Date 2020-09-21
Ticker Symbols
| Name | Symbol |
|---|---|
| WIENER BOERSE AG | ESF.VI |
| Frankfurt | ESF0.F |
| XETRA | ESF0.DE |
More Shares
Investors who hold EUROFINS SCI.EO 0,01 also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.



